323 related articles for article (PubMed ID: 30661282)
1. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia.
Mahale P; Aka P; Chen X; Pfeiffer RM; Liu P; Groover S; Mendy M; Njie R; Goedert JJ; Kirk GD; Glenn JS; O'Brien TR
J Viral Hepat; 2019 Jun; 26(6):738-749. PubMed ID: 30661282
[TBL] [Abstract][Full Text] [Related]
2. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
[TBL] [Abstract][Full Text] [Related]
3. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in hepatitis D: does it differ from hepatitis B monoinfection?
Abbas Z; Qureshi M; Hamid S; Jafri W
Saudi J Gastroenterol; 2012; 18(1):18-22. PubMed ID: 22249087
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B/D-Related Hepatocellular Carcinoma. A Clinical Literature Review.
Baskiran A; Atay A; Baskiran DY; Akbulut S
J Gastrointest Cancer; 2021 Dec; 52(4):1192-1197. PubMed ID: 34611832
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis D: A Review.
Negro F; Lok AS
JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
8. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
[TBL] [Abstract][Full Text] [Related]
9. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma.
Ji J; Sundquist K; Sundquist J
J Natl Cancer Inst; 2012 May; 104(10):790-2. PubMed ID: 22423008
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger.
Cenac A; Pedroso ML; Djibo A; Develoux M; Pichoud C; Lamothe F; Trepo C; Warter A
Am J Trop Med Hyg; 1995 Apr; 52(4):293-6. PubMed ID: 7537942
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
12. Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort.
d'Arminio Monforte A; Tavelli A; Salpini R; Piermatteo L; D'Anna S; Carrara S; Malagnino V; Mazzotta V; Brancaccio G; Marchetti GC; Rosselli Del Turco E; Rossotti R; Mussini C; Antinori A; Lo Caputo S; Ceccherini Silberstein F; Gaeta GB; Svicher V; Puoti M;
Liver Int; 2024 Feb; 44(2):603-613. PubMed ID: 38100128
[TBL] [Abstract][Full Text] [Related]
13. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies.
Kamal H; Fornes R; Simin J; Stål P; Duberg AS; Brusselaers N; Aleman S
J Viral Hepat; 2021 Oct; 28(10):1431-1442. PubMed ID: 34291520
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
[TBL] [Abstract][Full Text] [Related]
15. A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians.
Chen X; Oidovsambuu O; Liu P; Grosely R; Elazar M; Winn VD; Fram B; Boa Z; Dai H; Dashtseren B; Yagaanbuyant D; Genden Z; Dashdorj N; Bungert A; Dashdorj N; Glenn JS
Hepatology; 2017 Dec; 66(6):1739-1749. PubMed ID: 27880976
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis D virus dual infection increased the risk of hepatocellular carcinoma compared with hepatitis B virus mono infection: A meta-analysis.
Chang TE; Su CW; Huang YS; Huang YH; Hou MC; Wu JC
J Chin Med Assoc; 2022 Jan; 85(1):30-41. PubMed ID: 35006125
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis D Viremia Among Injection Drug Users in San Francisco.
Mahale P; Aka PV; Chen X; Liu P; Fram BJ; Wang AS; Simenel S; Tseng FC; Chen S; Edlin BR; Glenn JS; O'Brien TR
J Infect Dis; 2018 May; 217(12):1902-1906. PubMed ID: 29800369
[TBL] [Abstract][Full Text] [Related]
19. Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection: a study from Kure, Japan.
Tamura I; Kurimura O; Koda T; Ichimura H; Katayama S; Kurimura T; Inaba Y
J Gastroenterol Hepatol; 1993; 8(5):433-6. PubMed ID: 8218990
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis B and hepatitis D coinfection in asymptomatic blood donors in Iran.
Attaran MS; Sharifi Z; Hosseini SM; Samei S; Ataee Z
APMIS; 2014 Mar; 122(3):243-7. PubMed ID: 23879563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
